Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

Get detailed information on Aripiprazole, including pronunciation, uses, dosage guidelines ... prescribed for schizophrenia and depression. It regulates abnormal conditions like disturbed or ...

Teva's long haul to a turnaround of its business has been dealt a blow by the FDA, which has just declined to approve the company's long-acting formulation of schizophrenia drug risperidone.

Eleven patients with treatment-resistant schizophrenia participated in this clinical trial and received a combination of aripiprazole and clozapine. Patients had to have remained on a stable dose ...

The use and ethics of antipsychotic drugs in nursing homes is an ongoing discussion. Learn why these medications are ...

Rexulti’s typical dosage range for schizophrenia treatment in adults ... such as Abilify (aripiprazole). Withdrawal symptoms reported by people who abruptly stopped taking atypical ...

Use of the combination allowed a 16% reduction in the daily clozapine dose ( table II). After adding aripiprazole, we observed an increase in adverse drug events (nausea, vomiting, insomnia ...

On September 26, the U.S. Food and Drug Administration (FDA) approved a drug called Cobenfy to treat schizophrenia. Cobenfy is a combination of xanomeline and trospium chloride that has a novel ...

Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal. The US regulator has ...